Novel pharmacological approaches to treatment of drug overdose and addiction

Expert Review of Clinical Pharmacology

Volumn 2, Issue 1, 2009, Pages 1-4

  Zhan, Chang Guo ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; CHOLINESTERASE;

BLOOD BRAIN BARRIER; CATALYSIS; COCAINE DEPENDENCE; DRUG ABUSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG OVERDOSE; DRUG PENETRATION; DRUG TOLERABILITY; EDITORIAL; ENZYME ACTIVATION; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RESPIRATION DEPRESSION; THERMOSTABILITY;

EID: 70149097779     PISSN: 17512433     EISSN: None     Source Type: Journal    
DOI: 10.1586/17512433.2.1.1     Document Type: Editorial

References (28)

1. Landry DW. Immunotherapy for cocaine addiction. Sci. Am. 276, 42-45 (1997).
2. Gorelick DA. Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug Alcohol. Depend. 48, 159-165 (1997).
3. Redish AD. Addiction as a computational process gone awry. Science 306, 1944-1947 (2004).
4. Gorelick DA, Gardner EL, Xi ZX. Agents in development for the management of cocaine abuse. Drugs 64, 1547-1573 (2004).
5. Baird TJ, Deng SX, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J. Pharmacol. Exp. Ther. 295, 1127-1134 (2000).
6. Deng SX, de Prada P, Landry DW. Anticocaine catalytic antibodies. J. Immunol. Methods 269, 299-310 (2002).
7. Carrera MRA, Ashley JA, Parsons LH, Wirsching P, Koob GF, Janda KD. Suppression of psychoactive effects of cocaine by active immunization. Nature 378, 727-730 (1995).
8. Landry DW, Yang GX-Q. Anti-cocaine catalytic antibodies - a novel approach to the problem of addiction. J. Addict. Diseases 16, 1-17 (1997).
9. Landry DW, Zhao K, Yang GX-Q, Glickman M, Georgiadis TM. Antibody catalyzed degradation of cocaine. Science 259, 1899-1901 (1993).
10. Poet TS, McQueen CA, Halpert JR. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes. Drug Metab. Dispos. 24, 74-80 (1996).
11. Pan W-J, Hedaya MA. Cocaine and alcohol interactions in the rat: contribution of cocaine metabolites to the pharmacological effects. J. Pharm. Sci. 88, 468-476 (1999).
12. Sukbuntherng J, Martin DK, Pak Y, Mayersohn M. Characterization of the properties of cocaine in blood: blood clearance, blood to plasma ratio, and plasma protein binding. J. Pharm. Sci. 85, 567-571 (1996).
13. Lockridge O, Blong RM, Masson P, Froment, M-T, Millard CB, Broomfield CA. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase. Biochemistry 36, 786-795 (1997).
14. Bresler MM, Rosser SJ, Basran A, Bruce NC. Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1. Appl. Environ. Microbiol. 66, 904-908 (2000).
15. Cooper ZD, Narasimhan D, Sunahara RK et al. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Mol. Pharmacol. 70, 1885-1891 (2006).
16. Ko MC, Bowen LD, Narasimhan D et al. Cocaine esterase: interactions with cocaine and immune responses in mice. J. Pharmacol. Exp. Therap. 320, 926-933 (2007).
17. Gao D, Narasimhan DL, Macdonald J et al. Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Mol. Pharmacol. (2008)
18. Gao D, Zhan C-G. Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase. Proteins 62, 99-110 (2006).
19. Gao D, Zhan C-G. Modeling effects of oxyanion hole on the ester hydrolyses catalyzed by human cholinesterases. J. Phys. Chem. B 109, 23070-23076 (2005).
20. Zhan C-G, Deng S-X, Skiba JG et al. First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine. J. Comput. Chem. 26, 980-986 (2005).
21. Gao D, Cho H, Yang W et al. Computational design of a human butyrylcholinesterase mutant for accelerating cocaine hydrolysis based on the transition-state simulation. Angew. Chem. Int. Ed. 45, 653-657 (2006).
22. Zhan C-G, Zheng F, Landry DW. Fundamental reaction mechanism for cocaine metabolism in human butyrylcholinesterase. J. Am. Chem. Soc. 125, 2462-2474 (2003).
23. Zhan C-G, Gao D. Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine. Biophys. J. 89, 3863-3872 (2005).
24. Hamza A, Cho H, Tai H-H, Zhan C-G. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants. J. Phys. Chem. B 109, 4776-4782 (2005).
25. Pan Y, Gao D, Yang W et al. Computational redesign of human butyrylcholinesterase for anti-cocaine medication. Proc. Natl Acad. Sci. USA 102, 16656-16661 (2005).
26. Pan Y, Gao D, Yang W, Cho H, Zhan C-G. Free energy perturbation (FEP) simulation on the transition-states of cocaine hydrolysis catalyzed by human butyrylcholinesterase and its mutants. J. Am. Chem. Soc. 129, 13537-13543 (2007).
27. Zheng F, Yang W, Ko M-C et al. Most efficient cocaine hydrolase designed by virtual screening of transition States. J. Am. Chem. Soc. 130, 12148-12155 (2008).
28. Brimijoin S, Gao Y, Anker JJ et al. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology 33, 2715-2725 (2008).